GoodRx Holdings (GDRX) Total Non-Current Liabilities (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Total Non-Current Liabilities data on file, last reported at $1.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 119.33% year-over-year to $1.4 billion; the trailing twelve-month figure through Mar 2026 stood at $1.4 billion (up 119.33% YoY), and the FY2025 full-year result was $779.1 million, up 18.64% from the prior year.
• Total Non-Current Liabilities improved to $1.4 billion in Q1 2026, from $779.1 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $1.4 billion in Q1 2026 to a low of $634.0 million in Q1 2025.
• A 5-year average of $786.8 million and a median of $776.0 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities fell 22.16% in 2025 and surged 119.33% in 2026, its largest moves.
• Tracing GDRX's Total Non-Current Liabilities over 5 years: stood at $782.2 million in 2022, then climbed by 4.66% to $818.7 million in 2023, then fell by 19.79% to $656.7 million in 2024, then rose by 18.64% to $779.1 million in 2025, then surged by 78.49% to $1.4 billion in 2026.
• Business Quant data shows GDRX's Total Non-Current Liabilities at $1.4 billion in Q1 2026, $779.1 million in Q4 2025, and $717.2 million in Q3 2025.